Devyser Diagnostics AB (publ) (STO:DVYSR)
Sweden
· Delayed Price · Currency is SEK 86.00
-2.90 (-3.26%)
Mar 9, 2026, 5:29 PM CET
Devyser Diagnostics AB Revenue
In the year 2025, Devyser Diagnostics AB had annual revenue of 250.50M SEK with 15.49% growth. Devyser Diagnostics AB had revenue of 72.00M in the quarter ending December 31, 2025, with 12.15% growth.
Revenue
250.50M
Revenue Growth
+15.49%
P/S Ratio
5.72
Revenue / Employee
2.16M
Employees
116
Market Cap
1.43B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 28.24B |
| Getinge AB | 34.97B |
| Sectra AB | 3.52B |
| Medicover AB | 25.74B |
| Cereno Scientific AB | 44.27M |
| EQL Pharma AB | 425.75M |
| Carasent AB | 343.82M |
| Stille AB | 567.63M |